Executive Summary
Today's digest reveals a market bifurcated between sectors facing headwinds and those with strong catalysts. The tanker and shipping sector is under pressure, with Hafnia Ltd reporting a 24.8% decline in net income, while the cybersecurity and AI infrastructure spaces show robust growth, exemplified by SentinelOne's 20.5% revenue increase.
A significant wave of M&A and restructuring activity is reshaping the landscape, highlighted by BioXcel Therapeutics' Chapter 11 filing and BitGo's acquisition of NYDIG's trading business. Insider activity is mixed, with a notable CEO purchase in the struggling EdTech sector and routine tax-related sales at Marzetti Co. Capital allocation trends show a preference for share buybacks, with News Corp and Southern First Bancshares announcing new programs, while the IPO market shows signs of life with NorthStrive Acquisition Corp's $100M SPAC IPO. The most critical development is the NMPA approval of HUTCHMED's ATLED® for cholangiocarcinoma, a major catalyst for the biotech sector. Portfolio-level patterns indicate a defensive shift in capital allocation towards liquidity and debt management, as seen with Lockheed Martin's new credit facility and JBG SMITH's credit agreement amendment.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: 8-K · Schedule 13D · S-3 · 425 · 10-K · Form 4 · 10-Q · Schedule 13G
Tracking the trend? Catch up on the prior US SEC Filings Daily Market Digest digest from August 21, 2026.
Investment Signals (10)
- SentinelOne ↓ (BULLISH)▲
Revenue grew 20.5% YoY to $291.98M, driven by strong cybersecurity demand, while sales & marketing costs decreased 3.4% YoY, indicating improved operating leverage. The net loss widened due to a $24.4M restructuring charge, but the six-month net loss narrowed significantly.
- HUTCHMED ↓ (BULLISH)▲
NMPA approval of ATLED® (Fanregratinib) for FGFR2-fusion intrahepatic cholangiocarcinoma is a major regulatory milestone, unlocking a new market and validating its oncology pipeline.
- BitGo Holdings ↓ (BULLISH)▲
Acquisition of NYDIG's institutional trading business adds ~30 employees and institutional client relationships, expanding its platform. The deal enhances client asset stickiness and positions BitGo for growth in the institutional crypto market.
- 17 Education & Technology Group ↓ (BULLISH)▲
CEO Liu Chang bought 9,216 ADS at $2.16 (~$19.9K), a significant insider purchase signaling confidence in the company's turnaround prospects despite sector headwinds.
- News Corp ↓ (BULLISH)▲
Active $1B share buyback program, with daily repurchases disclosed, demonstrating strong capital return to shareholders and confidence in intrinsic value.
- Hafnia Ltd ↓ (BEARISH)▲
Total revenue declined 7.0% YoY to $1,525.4M, and net income dropped 24.8% to $310.2M, reflecting a challenging tanker market with no time charter revenue.
- BioXcel Therapeutics ↓ (BEARISH)▲
Filed for Chapter 11 bankruptcy with a stalking horse bid from Teva for $57.5M, indicating a complete loss of equity value. The company is being sold for a fraction of its potential.
- Kazia Therapeutics ↓ (BEARISH)▲
Reduced its maximum equity offering from $100M to $80M, signaling potential difficulty in raising capital or a need to limit dilution, which is negative for existing shareholders.
- Netcapital Inc. ↓ (BEARISH)▲
Received a Nasdaq delinquency notice for failing to file its 10-K, with a 60-day deadline to submit a compliance plan. Non-compliance risks delisting, which could severely impact stock liquidity.
- QumulusAI ↓ (BEARISH)▲
Net loss of $72.4M in H1 2026, a sharp reversal from a $10.3M profit in H1 2025, driven by a $73.9M loss on convertible notes. Total liabilities ballooned to $215.8M from $26.4M, indicating significant financial risk.
Risk Flags (10)
- BioXcel Therapeutics/Bankruptcy↓ [HIGH RISK]▼
Filed for Chapter 11, with a stalking horse bid of $57.5M from Teva. The company is being sold, and equity holders are likely to be wiped out.
- Netcapital Inc./Delisting Risk↓ [HIGH RISK]▼
Received a Nasdaq delinquency notice for late 10-K filing. Failure to regain compliance could lead to delisting, severely impacting liquidity and access to capital.
- QumulusAI/Financial Distress↓ [HIGH RISK]▼
Total liabilities surged to $215.8M from $26.4M, driven by convertible debt. The $73.9M loss on issuance of convertible notes is a major red flag for financial health.
- Hafnia Ltd/Industry Downturn↓ [MEDIUM RISK]▼
Net income declined 24.8% YoY with zero time charter revenue, indicating a severe downturn in the tanker market. Continued weakness could pressure dividends and balance sheet.
- NorthStrive Acquisition Corp/Going Concern↓ [HIGH RISK]▼
Auditor's report includes a going concern explanatory paragraph, noting insufficient capital to fund operations for one year. The SPAC has no target and an accumulated deficit of $2.9M.
- REST EZ Inc./Zero Revenue↓ [HIGH RISK]▼
Reported zero revenue for the second consecutive year, with net loss widening 86% to $14,700. Accumulated deficit deepened to $(333,264) and equity turned negative, indicating a non-viable business.
- KOSS Corp/International Decline↓ [MEDIUM RISK]▼
International sales in Sweden and Czech Republic dropped 68.4% and 70.6% respectively, signaling a loss of market share or operational issues in key European markets.
- INX Ltd/Negative Cash Flow↓ [HIGH RISK]▼
Cumulative adjusted operating cash flow worsened to negative $91.8M, with no proceeds from INX Token sales in H1 2026. The company is burning cash with no clear path to profitability.
- Element Solutions/Merger Termination↓ [MEDIUM RISK]▼
Mutual termination of the merger agreement with Solstice Advanced Materials, driven by shareholder feedback. While no termination fee is payable, the failed deal could signal strategic uncertainty.
- Aptorum Group/Increased Losses↓ [MEDIUM RISK]▼
Net loss for H1 2026 increased to $1,326,004 from $441,780 YoY, a 200% increase. The company is a development-stage biotech with no revenue, and the widening losses are concerning.
Opportunities (10)
- HUTCHMED/Regulatory Catalyst↓ (OPPORTUNITY)◆
NMPA approval of ATLED® for intrahepatic cholangiocarcinoma is a significant value driver. The drug targets a specific genetic mutation (FGFR2 fusion), creating a niche market opportunity.
- SentinelOne/Growth at a Reasonable Price↓ (OPPORTUNITY)◆
Revenue grew 20.5% YoY with improving cost control (sales & marketing down 3.4%). The stock may be undervalued if the market is overly focused on the one-time restructuring charge.
- BitGo Holdings/Institutional Crypto Expansion↓ (OPPORTUNITY)◆
The acquisition of NYDIG's trading business positions BitGo to capture more institutional flow in the crypto market. The deal adds 30 employees and client relationships, enhancing its platform stickiness.
- 17 Education & Technology Group/Insider Buying↓ (OPPORTUNITY)◆
CEO Liu Chang's purchase of 9,216 ADS at $2.16 is a strong signal of undervaluation. The company operates in the large EdTech market in China, and insider buying often precedes a turnaround.
- News Corp/Share Buyback Program↓ (OPPORTUNITY)◆
The active $1B buyback program, with daily repurchases, provides a floor for the stock price and signals management's confidence in the company's intrinsic value.
- Southern First Bancshares/Share Repurchase↓ (OPPORTUNITY)◆
The $10M buyback program (~2% of outstanding shares) is a capital management tool that can enhance shareholder value, especially if the stock is trading below book value.
- Lockheed Martin/Strong Credit Profile↓ (OPPORTUNITY)◆
The new $2.25B credit facility with no financial maintenance covenants and favorable interest rates (SOFR + 0.585% to 1.085%) reflects a strong credit profile and provides ample liquidity for operations and potential M&A.
- FG Merger II Corp./Boxabl Contract↓ (OPPORTUNITY)◆
The $233M potential purchase agreement for up to 1,580 ranch homes over three years provides a significant revenue pipeline for Boxabl, a modular housing company. The share-based incentive aligns buyer and seller interests.
- MediWound Ltd./Passive Stake↓ (OPPORTUNITY)◆
HOLD Alapkezelo Zrt. disclosed a 10.4% passive stake, indicating institutional interest. The stock may be undervalued, and the passive nature of the stake suggests a long-term investment horizon.
- BW LPG Ltd/Dividend Announcement↓ (OPPORTUNITY)◆
The company announced a cash dividend for Q2 2026, providing a yield opportunity for income-focused investors. The filing includes an earnings presentation, suggesting a transparent communication strategy.
Sector Themes (6)
- Shipping & Tanker Downturn (SECTOR THEME)◆
Hafnia Ltd's 24.8% decline in net income and zero time charter revenue highlight a severe downturn in the tanker market. This is a sector-wide trend, and investors should be cautious of other shipping companies reporting similar weakness.
- Cybersecurity Growth Persists (SECTOR THEME)◆
SentinelOne's 20.5% revenue growth, despite a challenging macro environment, underscores the secular demand for cybersecurity solutions. The sector remains a bright spot for growth investors.
- Biotech Regulatory Catalysts (SECTOR THEME)◆
HUTCHMED's NMPA approval for ATLED® is a positive signal for the biotech sector, particularly for companies with targeted therapies. Regulatory approvals can be significant value drivers.
- SPAC Market Activity (SECTOR THEME)◆
NorthStrive Acquisition Corp's $100M IPO and the Boxabl/Inflection Point Acquisition Corp. VII business combination indicate that the SPAC market is still active, though with a focus on quality targets and going concern risks.
- Capital Return via Buybacks (SECTOR THEME)◆
News Corp ($1B program) and Southern First Bancshares ($10M program) are actively returning capital to shareholders via buybacks, a trend that may continue as companies seek to support stock prices.
- Restructuring and M&A in Distressed Assets (SECTOR THEME)◆
BioXcel Therapeutics' Chapter 11 filing and sale to Teva, along with Element Solutions' terminated merger, show a trend of restructuring and M&A activity in distressed or underperforming companies.
Watch List (8)
- Netcapital Inc./Compliance Plan↓ (WATCH)👁
Must submit a compliance plan to Nasdaq by October 23, 2026. Failure to do so could lead to delisting. Monitor for any updates on the plan's acceptance.
- 👁
The stalking horse bid from Teva is subject to higher bids. Monitor for any competing bids that could change the outcome for stakeholders. Deadline for consummation is October 30, 2026.
-
As a SPAC with a going concern warning, the company must find a target quickly. Monitor for any business combination announcements.
- HUTCHMED/Commercial Launch↓ (WATCH)👁
Following the NMPA approval, monitor for commercial launch details, pricing, and initial sales figures for ATLED®. This will be a key indicator of the drug's market potential.
- SentinelOne/Earnings Call↓ (WATCH)👁
The next earnings call will provide updates on the restructuring progress and whether the cost savings are materializing. Watch for any changes to guidance.
- QumulusAI/Debt Covenants↓ (WATCH)👁
With total liabilities surging to $215.8M, monitor for any debt covenant violations or further dilutive financing activities.
- 👁
After the terminated merger, management reaffirmed its standalone strategy. Monitor for any new strategic initiatives, acquisitions, or changes in capital allocation.
- 👁
The acquisition of 455,296,932 shares from Success Flow International is still pending. Monitor for the closing of this transaction, which would significantly change the ownership structure.
Filing Analyses
(50)
27-08-2026
Siren ETF Trust's Siren DIVCON Leaders Dividend ETF (LEAD) is being voluntarily delisted from Cboe BZX Exchange, Inc. The security was suspended from trading on July 15, 2026, and liquidated on August 4, 2026, with the delisting effective September 7, 2026. This filing is a routine notification under SEC Rule 12d2-2(a)(2) and does not indicate any regulatory action against the issuer.
- · Suspension date: July 15, 2026
- · Liquidation date: August 4, 2026
- · Delisting effective date: September 7, 2026
- · Filing is a voluntary delisting, not a forced removal
28-08-2026
Lockheed Martin entered into a new $2.25 billion 364-day unsecured revolving credit facility on August 24, 2026, replacing its prior 364-day facility without early termination penalties. Concurrently, the company extended its existing $3.0 billion 5-year revolving credit agreement by one year to August 24, 2031. No borrowings were made under the new facility at closing, and the agreements contain no financial maintenance covenants.
- · The new 364-day facility matures on August 23, 2027, with an option to extend up to one additional year (to August 23, 2028) upon payment of a 0.50% conversion fee.
- · Interest rate options include Base Rate, Term SOFR plus margin, Daily Simple SOFR plus margin, or a competitive bid rate.
- · The Term SOFR Margin ranges from 0.585% to 1.085% per annum based on Lockheed Martin's senior unsecured long-term debt credit ratings.
- · The facility fee is 0.04% per annum on aggregate commitments, payable quarterly in arrears.
- · The 5-year revolving credit agreement was extended by one year from August 24, 2030 to August 24, 2031.
- · Events of default include failure to pay principal or interest within 5 days, breach of covenants, material misrepresentation, cross-default on Material Debt, bankruptcy, unsatisfied judgment over $300 million, and change of control.
- · No financial maintenance covenant is included in either agreement.
28-08-2026
Studio City International Holdings Limited filed a Form 6-K with the SEC for August 2026, attaching quarterly reports of its subsidiaries Studio City Finance Limited and Studio City Investments Limited. The filing is a routine periodic disclosure with no financial figures or operational updates provided.
- · The filing is a Form 6-K for the month of August 2026.
- · The report is signed by CFO Geoffrey Davis, CFA.
- · The company's principal executive offices are in Singapore and Hong Kong.
28-08-2026
INX Ltd reported a cumulative adjusted operating cash flow of negative $91.8 million as of June 30, 2026, worsening from negative $87.0 million at the end of 2025. The company generated no proceeds from INX Token sales in the first half of 2026, and the indicative pro rata distributable amount per INX Token stands at $0.24145.
- · Indicative Pro Rata Portion of the Distributable Amount per INX Token is $0.24145.
- · No proceeds from INX Token sales were recorded in the first half of 2026.
28-08-2026
ICICI Bank completed the issuance of USD 1 billion in Senior Unsecured Fixed Rate Notes under its USD 7.5 billion Global Medium Term Note Programme. The Notes are rated BBB by S&P and Baa3 by Moody's and will be listed on exchanges in India and Singapore. The offering is not registered in the U.S. and is not available for distribution there.
- · The Notes are rated BBB by S&P Global Ratings and Baa3 by Moody's Ratings.
- · The Notes will be listed on the Global Securities Market of the India International Exchange IFSC Limited, Debt Securities Market of the NSE IFSC Limited, and SGX-ST.
- · The issuance was completed on August 27, 2026, following a prior announcement on August 24, 2026.
- · The Notes are not registered under the U.S. Securities Act of 1933 and may not be offered or sold in the United States.
28-08-2026
Netcapital Inc. received a Nasdaq delinquency notice on August 24, 2026, for failing to file its Annual Report (Form 10-K) for the fiscal year ended April 30, 2026, violating Listing Rule 5250(c)(1). The company has 60 days (until October 23, 2026) to submit a compliance plan, with a possible extension to February 9, 2027. While the notice has no immediate effect on trading, non-compliance will be publicly broadcast, and there is no assurance Nasdaq will accept the plan or that compliance can be regained.
- · The delinquency notification was received on August 24, 2026, and the 8-K was filed on August 28, 2026.
- · The company's common stock (NCPL) and warrants (NCPLW) are listed on Nasdaq.
- · If the compliance plan is not accepted, the company can appeal to a Nasdaq Hearings Panel under Rule 5815(a).
- · A press release announcing the notice was issued on August 28, 2026, and is attached as Exhibit 99.1.
28-08-2026
Magnum Ice Cream Co B.V. disclosed share purchases for its Long Term Incentive Plans over four trading days (August 24-27, 2026), acquiring a total of 1,476,362 ordinary shares at an aggregate cost of approximately €25.6 million. The purchases were executed across Euronext, CBOE DXE, and Turquoise Europe, with the largest daily volume on August 25 (485,411 shares). No comparative prior-period data is provided, so period-over-period trends cannot be assessed.
- · Total shares purchased: 1,476,362 over four days.
- · Total purchase amount: approximately €25,582,265.03.
- · Average daily purchase prices ranged from €17.25315 to €17.45771.
- · Largest daily volume was on August 25, 2026 (485,411 shares).
- · Shares were bought on three venues: Euronext, CBOE DXE, and Turquoise Europe.
- · No prior-period or comparative data is provided in the filing.
28-08-2026
Hafnia Ltd reported its financial results for the six months ended June 30, 2026, with total revenue of $1,525.4 million, a decrease of 7.0% from $1,640.1 million in the same period of 2025. Net income declined to $310.2 million from $412.5 million, a drop of 24.8% year-over-year. While the company maintained a strong balance sheet with total assets of $4,089.3 million, the results reflect a significant downturn in profitability amid a challenging tanker market.
- · Revenue from voyage charters was $1,525.4 million in H1 2026, down from $1,640.1 million in H1 2025.
- · Revenue from time charters was $0 in H1 2026, compared to $0 in H1 2025 (no time charter revenue reported).
- · Total assets decreased slightly to $4,089.3 million as of June 30, 2026 from $4,100.0 million at December 31, 2025.
- · The company had multiple credit facilities outstanding, including a $715 million revolving credit facility and a $175 million borrowing base facility as of June 30, 2026.
- · Vista Shipping Pte Ltd had several credit facilities totaling approximately $340.9 million as of June 30, 2026.
- · The company reported no material acquisitions or disposals during the period.
28-08-2026
On August 24, 2026, PJ Millennium I Limited and PJ Millennium II Limited (wholly owned subsidiaries of PJ Millennium Limited Partnership) acquired 195,127,260 Class A ordinary shares of VNET Group, Inc. from Choice Faith Group Holdings Limited for an aggregate consideration of US$282,654,841 (US$1.4486 per share). This represents 11.4% of VNET's outstanding ordinary shares. The acquisition is part of a larger Share Purchase Agreement dated May 13, 2026, under which the Purchasers agreed to acquire a total of 650,424,192 Class A shares from two sellers for US$942,182,804; the remaining 455,296,932 shares from Success Flow International Investment Limited are still pending closing. The filing also reveals that Lochpine Capital Limited, the ultimate parent of the Purchasers, is 45% owned by CATL Investment Limited (a subsidiary of Contemporary Amperex Technology Co., Ltd., stock codes 300750.SZ and 03750.HK), 35% by Mr. Wang Hongbo, and 20% by Mr. Yee Chun Keung.
- · The per share price for the acquisition was US$1.4486 per Class A ordinary share.
- · Each of PJ Millennium I Limited and PJ Millennium II Limited acquired 97,563,630 Class A shares at the Seller B Shares Closing.
- · The remaining 455,296,932 Seller A Shares are to be acquired in a subsequent closing, with each Purchaser taking 227,648,466 shares.
- · Lochpine Capital Limited is the ultimate parent of the Purchasers and is held 45% by CATL Investment Limited (a CATL subsidiary), 35% by Mr. Wang Hongbo, and 20% by Mr. Yee Chun Keung.
- · VNET's ADSs, each representing six Class A ordinary shares, are listed on the Nasdaq Global Select Market under the symbol 'VNET'.
28-08-2026
BHP Group Ltd filed a Form 6-K with the SEC on August 28, 2026, providing additional information required by the JSE Listing Requirements regarding the classification of its dividend as a 'foreign dividend' for South African tax purposes. The dividend will be paid from the United Kingdom to shareholders on the South African branch register.
- · The dividend is classified as a 'foreign dividend' under South African income tax and Dividend Tax.
- · Payment to shareholders on the South African branch register will be made from the United Kingdom.
28-08-2026
BW LPG Ltd filed a Form 6-K with the SEC on August 28, 2026, announcing its financial results for the second quarter ended June 30, 2026 (Q2 2026). The filing includes a press release, interim financial report, earnings presentation, and a separate press release detailing the cash dividend for Q2 2026. The results and dividend information are incorporated by reference into the company's existing registration statements.
- · The filing includes four exhibits: press release for Q2 2026 financial results (Exhibit 99.1), Q2 2026 Interim Financial Report (Exhibit 99.2), Q2 2026 Earnings Presentation (Exhibit 99.3), and press release for Q2 2026 cash dividend (Exhibit 99.4).
- · The interim financial report (Exhibit 99.2) is incorporated by reference into the company's Form S-8 (File No. 333-280892) and Form F-3 (File No. 333-287996) registration statements, except for the 'Market Update' and 'Statements to the Interim Financial Information' sections.
- · The company's commission file number is 001-42008.
28-08-2026
Alterity Therapeutics Ltd filed a Form 6-K with the SEC for August 2026, attaching an Appendix 4G (corporate governance statement) and incorporating the filing by reference into its existing registration statements. The report is a routine foreign issuer disclosure with no financial results or material operational updates.
- · The filing incorporates by reference into multiple S-8 and F-3 registration statements (File Nos. 333-251073, 333-248980, 333-228671, 333-274816, 333-251647, 333-231417, 333-250076).
- · The company is described as a 'development stage enterprise'.
- · The report is signed by Chairman Julian Babarczy.
28-08-2026
Mitsubishi UFJ Financial Group, Inc. filed a Form 6-K with the SEC on August 28, 2026, as a routine foreign private issuer report. The filing contains no financial results, business updates, or material events beyond the administrative submission.
28-08-2026
BioXcel Therapeutics has filed for Chapter 11 bankruptcy and entered into a stalking horse asset purchase agreement with Teva Pharmaceuticals. Teva will acquire substantially all of the company's assets for $57.5 million upfront cash plus assumption of liabilities, with additional contingent milestone payments of up to $67.5 million for the pending sNDA for IGALMI® at-home use and up to $20 million in commercial milestone payments. The company has appointed Samir Saleem as Chief Restructuring Officer to oversee the restructuring process, and the transaction is subject to court approval and higher bids.
- · The stalking horse bid serves as the minimum floor bid, and the transaction is subject to higher or otherwise better bids in an auction process.
- · The transaction must be consummated by October 30, 2026, or either party may terminate the agreement.
- · The company has appointed a Strategic Process Committee of the Board to evaluate and implement restructuring or sale transactions.
- · Teva has agreed to serve as the stalking horse bidder, and the company has filed a motion under Section 363 of the Bankruptcy Code to sell assets.
28-08-2026
Caledonia Mining Corporation Plc filed a Form 6-K with the SEC on August 28, 2026, covering the month of August 2026. The filing includes a press release (Exhibit 99.1) dated August 28, 2026, but the content of the press release is not included in the filing text. The report is signed by CEO and Director John Mark Learmonth.
- · The filing is a routine Form 6-K for the month of August 2026.
- · The press release dated August 28, 2026 is attached as Exhibit 99.1 but its content is not disclosed in the filing text.
- · The company's principal executive office is located at 2 Mulcaster Street, St Helier, Jersey JE2 3NJ.
- · The company files annual reports under Form 20-F.
28-08-2026
Caledonia Mining Corporation Plc filed a Form 6-K with the SEC on August 28, 2026, attaching a press release of the same date. The filing is a routine foreign issuer report and contains no financial data or operational metrics.
- · The filing is a Form 6-K for the month of August 2026.
- · The attached press release (Exhibit 99.1) is dated August 28, 2026.
- · The registrant's principal executive office is in St Helier, Jersey.
28-08-2026
Niki BioSolutions, Inc. (formerly Aptorum Group Ltd) filed an S-3 shelf registration statement on August 28, 2026, following its July 20, 2026 merger with DiamiR Biosciences Corp. and domestication to Delaware. The company, now trading on Nasdaq under 'NIKI', reported a net loss of $1,326,004 for the six months ended June 30, 2026, compared to a net loss of $441,780 in the same period of 2025, representing a significant increase in losses. However, the company's net loss for the full year 2025 improved to $1,363,270 from $4,267,806 in 2024.
- · The company is a 'smaller reporting company' as defined under the Exchange Act.
- · The S-3 registration covers the offering of common stock, preferred stock, debt securities, warrants, subscription rights, and units.
- · A 1-for-10 reverse stock split was effective on July 20, 2026, and all per-share amounts and share counts have been retroactively restated.
- · The company's principal executive offices are at 116 Village Boulevard, Suite 200, Princeton, NJ 08540.
- · The CUSIP number for Niki Common Stock is 653942 102.
28-08-2026
NorthStrive Acquisition Corp I. consummated its initial public offering (IPO) on August 19, 2026, issuing 10,000,000 units at $10.00 per unit for gross proceeds of $100,000,000. Simultaneously, the company completed a private placement of 231,750 units to its sponsor for $2,317,500, bringing total proceeds to $102,317,500, of which $100,000,000 is held in trust. However, the auditor's report includes a going concern explanatory paragraph, noting the company lacks sufficient capital to fund operations for one year from the balance sheet date, and the company has an accumulated deficit of $2,908,777.
- · The company is a blank check company (SPAC) incorporated in the Cayman Islands on April 27, 2026, and has not yet commenced any operations.
- · The company has not selected any specific business combination target and has not engaged in any substantive discussions with any target.
- · The auditor's report includes an explanatory paragraph about substantial doubt regarding the company's ability to continue as a going concern, as it lacks capital resources to fund operations for one year from the balance sheet date.
- · Total shareholders' deficit is $2,908,271, driven by an accumulated deficit of $2,908,777.
- · The company has 4,829,998 Class B ordinary shares issued and outstanding, of which 629,998 are subject to forfeiture if the over-allotment option is not exercised.
- · The deferred underwriting fee of $3,500,000 is a non-current liability.
- · The company's sponsor is NorthStrive Sponsor I LLC.
28-08-2026
Element Solutions Inc (NYSE: ESI) announced the mutual termination of its merger agreement with Solstice Advanced Materials Inc., effective August 27, 2026. The decision was driven by shareholder feedback, and neither party will pay a termination fee. Management reaffirmed its standalone strategy focused on operational excellence, capital allocation, and new product introductions, with business momentum continuing in line with guidance.
- · No termination fee is payable by either party as a result of the mutual termination.
- · The merger agreement was terminated based on constructive shareholder feedback and discussions between the parties.
- · Management stated that business momentum continues unabated and in-line with guidance.
- · The company plans to continue its strategy focused on operational excellence, prudent capital allocation, and developing the best entrepreneurial team in the industry.
28-08-2026
Strategic Storage Trust VI, Inc. filed an S-4 registration statement on August 28, 2026, primarily related to a potential merger with Strategic Storage Growth Trust III, Inc. The filing details the company's debt portfolio, including multiple loans secured by self-storage properties in the U.S. and Canada, with several loans repaid and terminated in early 2025. The company has entered into interest rate swap agreements to fix variable rates on certain loans, with the SOFR swap rate improving from 2.29% to 1.54% between December 2025 and June 2026, while the CORRA swap remained at 3.03%.
- · Several loans were repaid and terminated in early 2025 without fees or penalties: National Bank of Canada – Burlington Loan, Cambridge Loan, North York Loan, Ontario Loan, First National Loan, and Bank of Montreal Loan.
- · As of June 30, 2026, the Huntington Credit Facility variable rate loan encumbers 11 properties (Phoenix I, Las Vegas, Phoenix II, Surprise, Apopka, Portland, Newark, Levittown, Chandler, St. Johns and Oxford) with an interest rate swap fixing SOFR at 1.54%.
- · As of December 31, 2025, the same Huntington loan had a swap fixing SOFR at 2.29%.
- · The National Bank of Canada four-property loan (Burlington, Cambridge, North York, Edmonton) has a swap fixing CORRA at 3.03% as of both December 31, 2025 and June 30, 2026.
- · The QuadReal seven-property fixed rate loan (Mississauga, Mississauga II, Burlington II, Hamilton, Vancouver, Woodbridge, Toronto) amounts are in USD based on the foreign exchange rate in effect as of the balance sheet date.
- · The Etobicoke, ONT development property is encumbered by a variable rate loan.
- · Interest rate derivatives were terminated during the first quarter of 2025.
- · A notional amount denominated in USD, designated as a cash flow hedge, was terminated during the first quarter of 2026.
28-08-2026
Inflection Point Acquisition Corp. VII (IPAC) is pursuing a business combination with Elroy Air, an autonomous cargo drone developer. The filing includes a transcript of a local news interview where Elroy Air CEO Andrew Clare discusses the company's participation in the FAA's EVTOL Integration Pilot Program and a public showcase at Houma-Terrebonne Airport. No financial terms, revenue figures, or specific deal metrics are disclosed in this communication.
- · The business combination will be submitted to IPAC shareholders for a vote.
- · IPAC has confidentially submitted a draft S-4 registration statement to the SEC.
- · Elroy Air's drone is a hybrid aircraft that runs on standard fuel and uses electric propulsion for safety benefits.
- · Customers mentioned include Bristow and FedEx.
- · The public showcase 'Liftoff Louisiana' took place on August 27, 2026, at Houma-Terrebonne Airport.
28-08-2026
Brookfield Infrastructure Partners L.P. filed a Form 6-K with the SEC on August 28, 2026, reporting two key corporate actions dated August 27, 2026: a Twelfth Amendment to its Amended and Restated Limited Partnership Agreement and a Guarantee Indenture among the partnership, BIPC Holdings Inc., Brookfield Infrastructure L.P., and Computershare Trust Company of Canada. The filing does not contain any financial results or performance metrics, and no period-over-period comparisons are available.
- · The Twelfth Amendment to the Limited Partnership Agreement was dated August 27, 2026.
- · The Guarantee Indenture was entered into on August 27, 2026, among Brookfield Infrastructure Partners L.P., BIPC Holdings Inc., Brookfield Infrastructure L.P., and Computershare Trust Company of Canada.
- · The filing is a routine foreign issuer report under Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934.
28-08-2026
Brookfield Infrastructure Corporation filed a Form 6-K with the SEC on August 28, 2026, reporting the execution of a Guarantee Indenture dated August 27, 2026, among Brookfield Infrastructure Partners L.P., BIPC Holdings Inc., Brookfield Infrastructure L.P., and Computershare Trust Company of Canada. The filing is a routine foreign issuer report and does not contain any financial results or performance data.
- · The Guarantee Indenture was entered into on August 27, 2026.
- · The filing is made under SEC Rule 13a-16 or 15d-16 as a foreign private issuer.
- · The company's principal executive office is located at 250 Vesey Street, 15th Floor, New York, New York 10281.
28-08-2026
News Corp filed an 8-K on August 28, 2026, disclosing its daily repurchase activity under the existing $1 billion stock buyback program, as required by Australian Securities Exchange (ASX) rules. The filing includes forward-looking statements regarding the company's intent to continue repurchasing Class A and Class B common stock from time to time, subject to market conditions and other factors. No specific financial results or material changes were reported.
- · The repurchase program authorizes up to $1 billion in aggregate of Class A and Class B common stock.
- · Disclosure is made to the ASX on a daily basis under ASX rules.
- · The filing includes forward-looking statements subject to risks including changes in stock price, market conditions, securities laws, and alternative investment opportunities.
28-08-2026
JBG SMITH Properties LP entered into a Second Amended and Restated Credit Agreement dated August 27, 2026, amending and restating its existing credit facility with a syndicate of banks led by Bank of America as Administrative Agent. The agreement provides a revolving credit facility with an interest rate margin ranging from 1.300% to 1.750% for SOFR loans and 0.300% to 0.750% for base rate loans, depending on the company's leverage ratio. The filing does not disclose the total commitment amount, drawn balance, or maturity date, limiting the ability to assess the full financial impact.
- · The agreement amends and restates the Existing Credit Agreement dated June 23, 2023, but is not a novation.
- · The facility includes a sustainability-linked adjustment mechanism (Section 2.18).
- · Borrower has an option to extend maturity (Section 2.20) and an amend-and-extend option (Section 2.21).
- · The agreement contains financial covenants including ratios for Total Outstanding Indebtedness to Capitalization Value, Combined EBITDA to Fixed Charges, Unencumbered Combined EBITDA to Unsecured Interest Expense, Unsecured Indebtedness to Capitalization Value of Unencumbered Assets, Secured Indebtedness to Capitalization Value, and Total Outstanding Secured Recourse Indebtedness to Capitalization Value.
- · The agreement includes provisions for incremental increases in commitments (Section 2.16).
- · The agreement includes a non-recourse provision to principals and general partner (Section 11.02).
28-08-2026
APS BDC, LLC disclosed via an 8-K that its subsidiaries and counterparties entered into a First Amendment to the Amended and Restated Loan and Security Agreement on August 24, 2026, with JPMorgan Chase Bank as administrative agent. The amendment modifies the terms of the existing credit facility, though the specific changes are redacted as commercially sensitive. As of the amendment date, each company and the portfolio manager represented that no default or market value event was continuing.
- · The amendment was effective as of August 24, 2026, conditioned on receipt of executed counterparts, legal opinions, corporate documents, and payment of fees.
- · The governing law of the amendment is New York law.
- · The amendment constitutes a Loan Document under the Loan and Security Agreement.
- · The original loan and security agreement was dated February 10, 2026.
- · The amendment redacts certain identified information as [***] because it is not material and would cause competitive harm if disclosed.
28-08-2026
BitGo Holdings, Inc. (NYSE: BTGO) announced the acquisition of NYDIG's institutional trading business, including derivatives, financing, and capital markets solutions, effective August 27, 2026. The deal adds approximately 30 NYDIG employees and institutional client trading relationships to BitGo, expanding its institutional markets platform. The acquisition is expected to enhance BitGo's trading and financing capabilities, but the filing does not disclose the purchase price or provide specific financial projections, and the transaction is subject to integration risks typical of such deals.
- · NYDIG's development pipeline exceeds 3 GW, with more than 1 GW of capacity deliverable in 2027 and 2028.
- · Stone Ridge Energy owns and operates assets responsible for roughly 3% of U.S. natural gas production.
- · The acquisition is expected to bolster and enhance the stickiness of client assets on platform (AOP).
28-08-2026
REST EZ Inc. (RTEZ) filed its 10-K annual report for the fiscal year ended March 31, 2026, reporting zero revenue for the second consecutive year. The company's net loss widened 86% to $14,700 from $7,900 in FY2025, driven by a doubling of general and administrative expenses to $14,700. While cash increased significantly to $3,856 from $300, the company's accumulated deficit deepened to $(333,264) and stockholders' equity turned negative to $(14,400) from a positive $300, indicating a deteriorating financial position.
- · The company had zero revenue and zero cost of goods sold for both FY2026 and FY2025.
- · General and administrative expenses increased 86% YoY to $14,700 from $7,900.
- · The company took on a loan from a related party of $18,256 in FY2026, compared to $0 in FY2025.
- · The number of outstanding shares more than doubled, increasing to 60,000,000 from 27,537,033.
- · The effective tax rate remained at 26% for both years, with a full valuation allowance against deferred tax assets.
- · No interest or income taxes were paid in either fiscal year.
28-08-2026
Koss Corp reported a net loss of $391,464 for FY2026, a significant improvement from a net loss of $874,831 in FY2025. Net sales increased 3.1% to $13,020,773, driven by a 21.2% rise in U.S. sales to $10,869,826. However, international sales declined sharply, with Sweden and Czech Republic dropping 68.4% and 70.6% respectively, and the company remained unprofitable on an operating basis.
- · Total assets decreased slightly from $37,184,609 to $36,658,764.
- · The company shifted its investment portfolio, moving from held-to-maturity securities to available-for-sale investments, resulting in an unrealized loss of $58,085.
- · Cash provided by operating activities turned positive at $439,207, compared to a use of $214,908 in the prior year.
- · Selling, general and administrative expenses increased 7.0% to $6,964,862, outpacing the 3.1% sales growth.
- · The company reported a basic and diluted loss per share of $0.04, improving from a loss of $0.09 in FY2025.
28-08-2026
Director Reese Scott was awarded 435 Common Stock. Reese Scott holds 435 shares after the transaction.
- · Director Reese Scott was awarded 435 Common Stock
28-08-2026
Chief Executive Officer Liu Chang bought 9,216 American depositary shares at $2.16 (~$19.9K). Liu Chang holds 86,905 shares after the transaction.
- · Chief Executive Officer Liu Chang acquired 481 American depositary shares at $2.37 (~$1.14K)
- · Chief Executive Officer Liu Chang acquired 1,359 American depositary shares at $2.33 (~$3.17K)
- · Chief Executive Officer Liu Chang bought 9,216 American depositary shares at $2.16 (~$19.9K)
28-08-2026
Chief Supply Chain Officer Viso Luis had withheld for taxes 152 Common Stock at $116.05 (~$17.6K). Viso Luis holds 2,044 shares after the transaction.
- · Chief Supply Chain Officer Viso Luis was awarded 527 Common Stock
- · Chief Supply Chain Officer Viso Luis had withheld for taxes 152 Common Stock at $116.05 (~$17.6K)
28-08-2026
VP, CFO and Asst. Secretary Pigott, Thomas K. had withheld for taxes 298 Common Stock at $116.05 (~$34.6K). Pigott, Thomas K. holds 18,011 shares after the transaction.
- · VP, CFO and Asst. Secretary Pigott, Thomas K. was awarded 1,026 Common Stock
- · VP, CFO and Asst. Secretary Pigott, Thomas K. had withheld for taxes 298 Common Stock at $116.05 (~$34.6K)
28-08-2026
President and CEO Ciesinski David Alan had withheld for taxes 1,611 Common Stock at $116.05 (~$187K). Ciesinski David Alan holds 59,522 shares after the transaction.
- · President and CEO Ciesinski David Alan was awarded 4,177 Common Stock
- · President and CEO Ciesinski David Alan had withheld for taxes 1,611 Common Stock at $116.05 (~$187K)
28-08-2026
President-Foodservice Division Bird Kristin had withheld for taxes 180 Common Stock at $116.05 (~$20.9K). Bird Kristin holds 6,285 shares after the transaction.
- · President-Foodservice Division Bird Kristin was awarded 623 Common Stock
- · President-Foodservice Division Bird Kristin had withheld for taxes 180 Common Stock at $116.05 (~$20.9K)
28-08-2026
Guardian Metal Resources PLC (GMTL) filed a Form 6-K with the SEC on August 28, 2026, providing a routine update as a foreign issuer. The filing lists key contacts including CEO Oliver Friesen, nominated adviser Cairn Financial Advisers LLP, joint brokers Berenberg and Tamesis Partners LLP, and financial PR firms Tavistock (UK) and Edelman Smithfield (US). No financial results, material transactions, or operational metrics were disclosed in this filing.
- · The filing is a Form 6-K (Foreign Issuer Report) submitted to the SEC on August 28, 2026.
- · The company maintains both UK and US financial PR representation through Tavistock and Edelman Smithfield respectively.
28-08-2026
Belpointe PREP, LLC disclosed its quarterly NAV as of June 30, 2026, reporting total assets of $761.5M, total liabilities of $306.5M, and a NAV of $455.0M. NAV per Class A unit stood at $116.37, based on 3,909,902 units outstanding. The filing provides a routine quarterly update with no comparative prior-period data, so no period-over-period trends are available.
- · The NAV determination was approved by the Company in accordance with its valuation policies.
- · NAV per Class A unit is calculated after allocation/accrual of management fees, gains/distributions to the Manager (Class B units), and expense reimbursements.
- · The Company cautions that NAV is not a guarantee of realizable value upon sale and that Class A units may trade at a discount or premium on the NYSE American.
28-08-2026
Melco Resorts & Entertainment LTD filed a Form 6-K with the SEC on August 28, 2026, attaching the quarterly report of its subsidiary, Melco Resorts Finance Limited. The filing was signed by CFO Geoffrey Davis and covers the month of August 2026. No specific financial figures or performance data are disclosed in the filing itself, only the cover and exhibit index.
- · The filing is a Form 6-K (Report of Foreign Issuer) for the month of August 2026.
- · The registrant's principal executive offices are in Singapore and Hong Kong.
- · The attached exhibit is the quarterly report of Melco Resorts Finance Limited (Exhibit 99.1).
28-08-2026
Jiayin Group Inc. reported its second quarter 2026 unaudited financial results on August 28, 2026. The filing includes a press release with key financial metrics for the quarter. The results show a mixed performance with revenue growth in certain segments but declines in others.
- · The filing is a Form 6-K submitted to the SEC for the month of August 2026.
- · The press release covers unaudited financial results for the second quarter of 2026.
- · The company's principal executive offices are located in Shanghai, China.
28-08-2026
CXJ Group Co., Limited filed a Form NT 10-K on August 28, 2026, indicating that its annual report for the fiscal year ended May 31, 2026, will be delayed. The company cited the need for additional time to complete the filing, but does not anticipate any significant change in results of operations from the prior fiscal year. All other periodic reports have been filed on time.
- · Filing deadline extension: annual report due on or before the 15th calendar day following the prescribed due date.
- · All other periodic reports under Section 13 or 15(d) of the Exchange Act for the preceding 12 months have been filed.
- · No significant change in results of operations is anticipated compared to the last fiscal year.
28-08-2026
Boxabl Inc. entered into a Product Purchase Agreement with LC Vegas Acquisitions, LLC for the sale of up to 1,580 ranch homes over three years, with an aggregate potential value of approximately $233 million. The agreement includes a share-based incentive for the buyer to place significant orders, but the buyer is not obligated to purchase any homes and may terminate at any time. The filing also covers the unregistered issuance of equity securities as part of the incentive.
- · The buyer is responsible for site development, local permits, installation on foundations, zoning, utilities, interior finishes, occupancy permits, roofing, cladding, and any garage or carport.
- · The company is responsible for engineering, design, interior mechanicals, plumbing, electrical, securing Nevada state approval for plan sets, and local oversight/project management for site installation.
- · The agreement may be terminated at any time by the buyer upon written notice; upon termination, the buyer pays for approved work and expenses incurred by the company.
- · The incentive shares are subject to beneficial ownership limitations.
- · The company must register the incentive shares for resale within 120 days after the final payment associated with the purchase order is received.
28-08-2026
Kazia Therapeutics Ltd filed a prospectus supplement on August 28, 2026, reducing the maximum aggregate offering price of ADSs under its existing Sales Agreement with Leerink Partners from $100M to $80M. This adjustment reflects a decrease in the potential equity capital available to the company.
- · The prospectus supplement was filed under Rule 424(b)(5) of the Securities Act of 1933.
- · The Sales Agreement was originally dated March 17, 2026.
- · The registration statement on Form F-3 (File No. 333-294392) was initially filed on March 18, 2026.
28-08-2026
SentinelOne reported Q2 FY2027 revenue of $291.98M, up 20.5% YoY from $242.18M, driven by strong demand for its cybersecurity platform. However, the company posted a net loss of $93.4M, wider than the $72.02M loss in the same quarter last year, due to a $24.4M restructuring charge and rising operating expenses. For the six-month period, net loss narrowed to $169.56M from $280.21M, benefiting from a prior-year income tax provision of $136.76M.
- · Restructuring charge of $24.4M in Q2 FY2027, up from $3.9M in Q2 FY2026, a 529% increase.
- · Sales and marketing expense decreased 3.4% YoY to $123.5M in Q2 FY2027, indicating cost control.
- · Interest income fell 49.5% YoY to $6.2M, likely due to lower investment yields or reduced cash balances.
- · Total assets declined 2.3% from $2.44B (Jan 31, 2026) to $2.38B (Jul 31, 2026).
- · Deferred revenue (current) decreased 9.0% from $549.8M to $500.5M, potentially signaling slower billings.
- · Accumulated deficit grew to $2.25B from $2.08B at the start of the fiscal year.
- · The company did not repurchase any common stock in the current period, compared to $52.7M in buybacks in the prior-year period.
28-08-2026
QumulusAI reported a net loss of $72.4M for H1 2026, a sharp reversal from a $10.3M net profit in H1 2025, driven by a $73.9M loss on issuance of convertible notes. Total revenue more than doubled to $10.1M, led by a 5.9x surge in compute power revenue to $7.7M, though mining hosting services revenue declined 51% to $1.6M. The company ended the period with $39.9M in cash and restricted cash, up from $11.7M at year-end 2025, but total liabilities ballooned to $215.8M from $26.4M, primarily due to new convertible debt and USD.AI protocol loans.
- · Operating loss widened to $13.2M in H1 2026 from $3.1M in H1 2025.
- · Depreciation and amortization expense increased to $9.5M in H1 2026 from $1.5M in H1 2025.
- · The company recorded a $12.6M gain on sale of equity method investments in H1 2026.
- · Net cash provided by operating activities was $22.3M in H1 2026 vs $0.8M used in H1 2025.
- · Capital expenditures (purchase of property and equipment) were $36.8M in H1 2026.
- · Shareholders' equity swung to a deficit of $0.8M as of June 30, 2026 from positive $65.3M at Dec 31, 2025.
- · The company had $55.5M in convertible note payable and $18.9M in USD.AI protocol loans as of June 30, 2026.
- · Goodwill of $31.4M was recorded from a prior acquisition.
28-08-2026
Alterity Therapeutics Limited filed a Form 6-K with the SEC on August 28, 2026, submitting its Corporate Governance Statement as an exhibit. The filing is a routine foreign issuer report and does not contain any financial results, operational updates, or material business developments.
28-08-2026
HOLD Alapkezelo Zrt. filed a Schedule 13G/A with the SEC disclosing beneficial ownership of 1,348,323 common shares of MediWound Ltd., representing 10.4% of the outstanding shares as of August 27, 2026. The filing is a routine passive ownership disclosure under Rule 13d-1(c) and does not indicate any change in control intent.
- · The filing is an amendment (SC 13G/A) to a prior Schedule 13G.
- · The shares are held for passive investment purposes, not to influence control.
- · The outstanding share count of 12,910,278 is based on the issuer's 6-K filed on August 13, 2026.
28-08-2026
HUTCHMED (China) Limited announced that the China National Medical Products Administration (NMPA) has approved ATLED® (Fanregratinib) for the treatment of patients with FGFR2-fusion/rearrangement intrahepatic cholangiocarcinoma. This regulatory approval marks a significant milestone for the company's oncology pipeline. No financial figures or period-over-period comparisons were provided in this filing.
- · ATLED® (Fanregratinib) is approved for FGFR2-fusion/rearrangement intrahepatic cholangiocarcinoma.
- · The approval was granted by the China National Medical Products Administration (NMPA).
- · The filing was made as a Form 6-K for the month of August 2026.
28-08-2026
AIR Global PLC filed a registration statement on Form F-1 with the SEC on August 28, 2026, registering up to 154,623,867 ordinary shares for resale by selling shareholders. The shares were issued in connection with the May 15, 2026 business combination between Cantor Equity Partners III, Inc. and AIR Limited. The company will not receive any proceeds from the sale of these shares by selling shareholders.
- · The registration statement is filed under Rule 429 and also constitutes post-effective amendment no. 1 to the F-4 Registration Statement (File No. 333-294714), which was declared effective on April 22, 2026.
- · The business combination was consummated on May 15, 2026, pursuant to a Business Combination Agreement dated November 7, 2025.
- · The company is an emerging growth company, a foreign private issuer, and a controlled company under U.S. federal securities laws.
- · The company's ordinary shares are listed on Nasdaq under the symbol 'AIIR'.
28-08-2026
Alterity Therapeutics Limited, a development-stage biotech, filed a Form 6-K with the SEC on August 28, 2026, solely to submit an exhibit (99.1) regarding an application for quotation of securities (ATH). The filing contains no financial results or operational updates, and the company remains in the development stage with no revenue-generating products.
- · The Form 6-K is incorporated by reference into multiple registration statements on Form S-8 and Form F-3.
- · The company is a development-stage enterprise, indicating no commercial products or revenue yet.
Get daily alerts with 10 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 50 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: US SEC Filings Daily Market Digest
🇺🇸 More from United States
View all →August 21, 2026
S&P 500 Consumer Discretionary Sector SEC Filings — August 21, 2026
S&P 500 Consumer Discretionary Sector SEC Filings
August 21, 2026
US Executive Compensation Proxy SEC Filings — August 21, 2026
US Executive Compensation Proxy SEC Filings
August 21, 2026
US Merger & Acquisition SEC Filings — August 21, 2026
US Merger & Acquisition SEC Filings
August 21, 2026
USA Insider Trading Pulse — August 21, 2026
USA Insider Trading Pulse